Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.97 |
| ▸ | MAPT | P10636 | 5/20 | 0.97 |
| ▸ | BLM | P54132 | 4/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.97 |
| ▸ | HPGD | P15428 | 4/20 | 0.97 |
| ▸ | HTT | P42858 | 4/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.97 |
| ▸ | THRB | P10828 | 3/20 | 0.97 |
| ▸ | CASP1 | P29466 | 3/20 | 0.97 |
| ▸ | RECQL | P46063 | 3/20 | 0.97 |
| ▸ | CASP7 | P55210 | 3/20 | 0.97 |
| ▸ | TERT | O14746 | 3/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.97 |
| ▸ | MITF | O75030 | 2/20 | 0.97 |
| ▸ | NSD2 | O96028 | 2/20 | 0.97 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | TP53 | P04637 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homidium SCHEMBL27609 | 0.99 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL31511751 | 0.99 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL21647365 | 0.99 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL29391335 | 0.99 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL612343 | 0.97 | MEN1 (0.97) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL1879927 | 0.97 | MEN1 (0.97) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL11023665 | 0.97 | MEN1 (0.97) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL3025214 | 0.97 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL20520 | 0.97 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E | |
| Homidium SCHEMBL7751164 | 0.97 | MEN1 (1.00) | MEN1KMT2AMAPTBLMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118217380-A | Application of JWA polypeptide in preparing anti-hepatitis or anti-hepatic fibrosis medicine | 周建伟 | 2024-06-21 | — | — | CN | disclosed |
| WO-2024026841-A1 | DRUG-LOADED ERYTHROCYTE MEMBRANE NANOPARTICLE, METHOD FOR PREPARING SAME, AND USE THEREOF | 苏州大学 | 2024-02-08 | — | — | WO | disclosed |
| CN-116509902-B | Probiotic agent for improving mental diseases caused by environmental pollution by adjusting intestinal-brain axis and application thereof | 微康益生菌(苏州)股份有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-117045665-A | New application of acteoside | 新疆医科大学第一附属医院 | 2023-11-14 | — | — | CN | disclosed |
| JP-2023121866-A | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | マム ホールディングス オブ ウエスト フロリダ， リミテッド ライアビリティ カンパニー | 2023-08-31 | — | — | JP | disclosed |
| CN-116509902-A | Probiotic agent for improving mental diseases caused by environmental pollution by adjusting intestinal-brain axis and application thereof | 微康益生菌(苏州)股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-113509471-B | Application of AKT2 inhibitor in preparation of medicine for treating doxorubicin-induced myocardial injury | 中国药科大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-112999153-B | Nano micelle carrying chemotherapeutic drug/photosensitizer and preparation method and application thereof | 苏州大学 | 2023-04-07 | — | — | CN | disclosed |
| US-20230021477-A1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | MAM Holdings of West Florida, L.L.C. | 2023-01-26 | — | — | US | disclosed |
| WO-2022188046-A1 | CHEMOTHERAPEUTIC DRUG-/PHOTOSENSITIZER-LOADED NANOMICELLE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州大学 | 2022-09-15 | — | — | WO | disclosed |
| CN-114014875-B | Degradable near-infrared photosensitizer, preparation method and application thereof | 北京协同创新研究院 | 2022-08-19 | — | — | CN | disclosed |
| CN-113735886-B | PDT compounds, methods of preparation and uses thereof | 北京大学 | 2022-06-03 | — | — | CN | disclosed |
| CN-114014875-A | Degradable near-infrared photosensitizer, preparation method and application thereof | 北京协同创新研究院 | 2022-02-08 | — | — | CN | disclosed |
| EP-3468571-B1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | MAM HOLDINGS OF WEST FLORIDA L L C (US) | 2022-01-26 | — | — | EP | disclosed |
| CN-113735886-A | PDT compounds, methods of preparation and uses thereof | 北京大学 | 2021-12-03 | — | — | CN | disclosed |
| EP-3468571-A1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | Mam Holdings Of West Florida, L.L.C. (US) | 2019-04-17 | — | — | EP | disclosed |
| US-20180140641-A1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | MAM Holdings of West Florida, L.L.C. | 2018-05-24 | — | — | US | disclosed |
| WO-2017218535-A1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | MAM Holdings of West Florida, L.L.C. (US) | 2017-12-21 | — | — | WO | disclosed |
| US-20170354692-A1 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | MAM Holdings of West Florida, L.L.C. | 2017-12-14 | — | — | US | disclosed |